Artificial intelligence in life sciences is being held back by data issues and skills shortage, according to research
The Pistoia Alliance has announced that it is launching the next phase of its blockchain project which aims to identify potential applications for the use of blockchain in the life sciences
A new report from the Pistoia Alliance finds that multi-disciplinary innovation, the implementation of new technologies, new approaches to research, the digitisation of R&D and healthcare, and academic contributions to biologics drug R&D are all key trends in the life sciences industry.
The Pistoia Alliance, has announced the results of a survey on the adoption of blockchain in the pharmaceutical and life science industries
The Pistoia Alliance, a global, not for profit alliance that works to lower barriers to innovation in life sciences R&D, has announced a number of milestones in its Chemical Safety Library (CSL) Service project, launched in March 2017.
The Pistoia Alliance has released results of a survey that found that 72 per cent of science professionals believe their sector is lagging behind other industries in the development of AI
At The Pistoia Alliance’s annual EU member conference in London, president of the Pistoia Alliance, Dr Steve Arlington, urged stakeholders to come together to help technology continue to drive change in the industry and to amplify R&D budgets
The Pistoia Alliance, has announced the launch of the User Experience for Life Sciences (UXLS) Toolkit - to help life science companies improve user experience in line with other global industries
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
